BFRI - Biofrontera Inc logo

Biofrontera Inc

BFRI
Net income grew 100% of yearsRevenue grew 100% of years1Y
Compare BFRI Hold

Biofrontera Inc. commercializes biopharmaceutical products for dermatological conditions in the U.S. It specializes in photodynamic therapy and offers treatments like Ameluz and RhodoLED lamps for actinic keratosis and other skin issues.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 1 year ago โ†’$879today

Score Overview

1 Year
Scoreโ€”
Net Growth39.59%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth10.72%
Rev TrendGrew
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth83.12%
Net Trend80%
Net Income Consistency
Rev Growth91.60%
Rev TrendEvery year
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Biofrontera Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. BFRI does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-06
$ 0.93โ€”
1 Year2025-10-06
$ 1.06-12.08%
All Time2021-10-29
$ 88.20-98.94%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 46M-$ 6M$ 4M
2025$ 41M-$ 10M$ 6M
2024$ 37M-$ 17M$ 5M
2023$ 34M-$ 20M$ 1M
2022$ 28M-$ 640K$ 27M
IPO2021$ 24M-$ 37M$ 24M
BFRI - Biofrontera Inc logo

Biofrontera Inc fundamental performance

Across Biofrontera Inc's full reported history, from 2021 to 2025, revenue grew from $ 24M to $ 41M and net income went from -$ 37M to -$ 10M. Revenue increased in 100% of the years measured; net income in 80%.

Membership

Explore BFRI with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,122 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies